Dentists largely stopped using cocaine as a local anesthetic between 1905 and 1920, after safer synthetic alternatives became available. The transition wasn’t a single moment but a gradual shift driven by the introduction of Novocain in 1905, federal regulation in 1914, and practical innovations in how anesthetics were delivered through the 1920s.
How Cocaine Became a Dental Anesthetic
Cocaine’s use in dentistry began in 1884, when William Halsted performed the first nerve block using the drug. That same year, Carl Koller demonstrated cocaine’s anesthetic effects on the eye at the Medical Society of Vienna, sparking widespread interest across medicine. Dentists quickly adopted it because cocaine did something no other available substance could: it completely numbed a specific area of the mouth, making tooth extractions and other procedures painless for the first time.
Cocaine also had a built-in advantage for surgical work. It naturally constricts blood vessels, which reduced bleeding at the treatment site and prolonged the numbing effect. For dentists working in the late 1800s, this was a remarkable leap forward from the options available, which were essentially general anesthesia with ether or chloroform, or nothing at all.
Why Dentists Needed Something Safer
The same properties that made cocaine effective also made it dangerous. Beyond blocking pain signals in nerves, cocaine floods the brain with dopamine, norepinephrine, and serotonin. That produces euphoria, raises heart rate, and carries a real risk of addiction. Dentists and their patients were not immune. Reports of toxicity and dependence accumulated through the 1890s, and the drug’s stimulant effects on the heart made it unpredictable at higher doses. The medical community recognized fairly quickly that cocaine’s risks were disproportionate to what dental work actually required.
Novocain Changed Everything
In 1904, German chemist Alfred Einhorn synthesized procaine hydrochloride while working for the Bayer company. It was soon marketed under the trade name Novocain, and it represented a fundamentally different kind of anesthetic. Like cocaine, Novocain blocks the sodium channels in nerve fibers that transmit pain signals. Unlike cocaine, that’s all it does. It has no effect on the brain’s reward system, produces no euphoria, and carries zero addiction risk.
The tradeoff was that Novocain doesn’t constrict blood vessels on its own, so dentists began pairing it with epinephrine to control bleeding and extend the numbing effect. This combination worked well and became standard practice. By 1914, sterile ampules of Novocain solution were commercially available, and in 1921, the anesthetic cartridge (the small glass tube still recognizable in dental offices today) hit the market. These practical innovations made Novocain far easier to use, store, and dose accurately than cocaine had ever been.
For most dental practices, the shift to Novocain was effectively complete by the early 1920s.
Federal Law Accelerated the Shift
The Harrison Narcotics Tax Act of 1914 didn’t ban cocaine outright, but it made using it far more cumbersome. The law required anyone who distributed narcotics, including dentists, to register with the federal government, pay a tax, and keep detailed records of every transaction open to government inspection. Cocaine and opium-based drugs were grouped together under the law, both classified as potentially habit-forming and associated with crime.
For dentists who already had a perfectly good alternative in Novocain, the regulatory burden removed any remaining incentive to keep cocaine in their offices. The Harrison Act didn’t single-handedly end cocaine’s dental use, but it ensured that the transition already underway became permanent. By the mid-1920s, cocaine in a dental chair was essentially a thing of the past.
Lidocaine Replaced Novocain, Too
Novocain’s reign as the go-to dental anesthetic didn’t last forever either. Lidocaine was synthesized in 1943 and introduced commercially in 1948, becoming the first of a newer class of anesthetics that lasted longer, worked more reliably, and caused fewer allergic reactions. Novocain was eventually withdrawn from sale in many countries because it was absorbed into the bloodstream too quickly, where it could reach problematically high levels.
Lidocaine and its relatives (articaine, mepivacaine, bupivacaine) are what your dentist uses today. They all descend from the same basic principle that Novocain established: block pain signals in the nerve without touching the brain’s chemistry.
Cocaine Still Has a Narrow Medical Role
Cocaine hasn’t disappeared from medicine entirely. It remains available as a topical anesthetic for procedures involving the nose, mouth, and throat, where its unique combination of numbing and blood vessel constriction is occasionally useful. The Mayo Clinic lists it as a current topical anesthetic applied to mucous membranes before certain examinations or surgeries. In this controlled, surface-level application, the risk of addiction is minimal.
That said, you won’t encounter it in a routine dental visit. Its modern medical use is limited to specific surgical scenarios, typically in ear, nose, and throat procedures rather than dentistry. The synthetic anesthetics developed over the past century do the job better, more safely, and without the legal complexity that comes with handling a controlled substance.